Avoiding Overtreatment of Ductal Carcinoma in situ

被引：7
|
作者：
van der Borden, Carolien L. [1 ]
Stoffers, Saskia [1 ]
Lips, Esther H. [1 ]
Wesseling, Jelle [1 ,2 ,3 ]
机构：
[1] Div Mol Pathol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands
[2] Dept Pathol, Div Diagnost Oncol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands
[3] Leiden Univ, Dept Pathol, Med Ctr, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands
来源：
TRENDS IN CANCER | 2019年 / 5卷 / 07期
关键词：
INVASIVE BREAST-CANCER; RADIOTHERAPY; DCIS;
D O I：
10.1016/j.trecan.2019.05.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Ductal carcinoma in situ (DCIS), a precursor to invasive breast cancer (IBC), represents 25% of all breast neoplasms. Most are harmless, but some progress to IBC. Yet, almost all DCIS are treated. Learning how to distinguish harmless from hazardous DCIS will save many women with harmless DCIS the burden of overtreatment.
引用
收藏
页码：391 / 393
页数：3
相关论文
共 50 条
  • [1] The LORIS Trial: Addressing Overtreatment of Ductal Carcinoma In Situ
    Francis, A.
    Fallowfield, L.
    Rea, D.
    CLINICAL ONCOLOGY, 2015, 27 (01) : 6 - 8
  • [2] Overtreatment of Low-Grade Ductal Carcinoma In Situ
    Fallowfield, Lesley
    Francis, Adele
    JAMA ONCOLOGY, 2016, 2 (03) : 382 - 383
  • [3] Renaming Ductal Carcinoma in Situ: Would Removing "Carcinoma" Reduce Overtreatment?
    Javid, Sara H.
    Fang, L. Christine
    Korde, Larissa
    Anderson, Benjamin O.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2014, 12 (04): : 599 - 602
  • [4] Quantifying the natural history and overtreatment rate of ductal carcinoma in situ
    Ryser, Marc D.
    Weaver, Donald L.
    Marks, Jeffrey R.
    Hyslop, Terry
    Hwang, E. Shelley
    CANCER RESEARCH, 2018, 78 (04)
  • [5] Ductal carcinoma in situ of the breast: finding the balance between overtreatment and undertreatment
    Delaloge, Suzette
    Khan, Seema Ahsan
    Wesseling, Jelle
    Whelan, Timothy
    LANCET, 2024, 403 (10445): : 2734 - 2746
  • [6] Paradigm Shift toward Reducing Overtreatment of Ductal Carcinoma In Situ of Breast
    Sagara, Yasuaki
    Julia, Wong
    Golshan, Mehra
    Toi, Masakazu
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [7] Toward Minimizing Overtreatment and Undertreatment of Ductal Carcinoma In Situ in the United States
    Smith, Grace L.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (11) : 1172 - +
  • [8] Overdiagnosis and overtreatment of breast cancer -: Rates of ductal carcinoma in situ:: a US perspective
    Kumar, AS
    Bhatia, V
    Henderson, IC
    BREAST CANCER RESEARCH, 2005, 7 (06) : 271 - 275
  • [9] Mammary ductal carcinoma in situ: A possible overtreatment? Can we do less?
    Cutuli, Bruno
    IMAGERIE DE LA FEMME, 2018, 28 (02) : 144 - 151
  • [10] Overdiagnosis and overtreatment of breast cancer: Progression of ductal carcinoma in situ: the pathological perspective
    J Louise Jones
    Breast Cancer Research, 8
12345